Hepatitis B Blood Test Results Explained
What HBsAg, anti-HBs and anti-HBc mean on their own and combined, and how Australian GPs tell past infection, vaccination immunity and current infection apart.
Free to use · No credit card · Works with any Australian lab
· · Reviewed against the sources listed at the end of this page.
The Quick Answer
A hepatitis B serology panel usually reports three results together: HBsAg (surface antigen, shows if the virus is currently present), anti-HBs (surface antibody, shows if you are immune), and anti-HBc (core antibody, shows if you have ever been exposed to the actual virus, as opposed to the vaccine).
On their own, none of the three results tells the full story. The combination of all three is what matters, and the five common combinations below cover almost every result an Australian GP will see. Most results turn out to mean either full immunity or no exposure at all, and a positive current infection is the least common pattern.
Read all three together. HBsAg answers whether the virus is present right now. Anti-HBs and anti-HBc together answer whether you have ever been exposed and whether you are protected. Any one result on its own can point the wrong way.
How the Three Tests Are Reported
Australian pathology labs report each of the three core hepatitis B tests as a simple positive, negative, or occasionally an equivocal (borderline) result, rather than a numeric reference range. Some labs also report a numeric titre for anti-HBs once it is positive, which is useful for assessing vaccine response strength.
HBsAg
Reported as negative or positive. Negative is the expected result in someone without a current infection. A positive result is generally confirmed on a repeat sample before it is acted on.
Anti-HBs
Reported as negative or positive, often with a titre in mIU/mL once positive. A titre of 10 mIU/mL or above is generally accepted as protective immunity after vaccination.
Anti-HBc
Reported as negative or positive (total anti-HBc, which includes both IgM and IgG). A separate IgM anti-HBc test is added when a new or recent infection needs to be distinguished from an old one.
The Five Serology Patterns, Explained
Match your three results against the rows below. This is how Australian GPs read a hepatitis B panel in practice.
Never exposed, not immune
You have never encountered hepatitis B and have not been vaccinated, or the vaccine did not produce a lasting antibody response. Vaccination is recommended, particularly if you have an ongoing risk of exposure through work, travel, household contact, or if you are planning immunosuppressive treatment.
Immune from vaccination
This is the expected pattern after a successful hepatitis B vaccination course. Anti-HBs is the protective antibody produced by the vaccine, and its presence without anti-HBc confirms the immunity came from the vaccine rather than a natural infection. No further action is needed.
Past infection, resolved and immune
You were infected with hepatitis B at some point in the past, your immune system cleared the virus, and you now carry lasting protective antibodies. This is a common and reassuring finding, often picked up incidentally on a routine blood test years after the original infection, which may never have caused noticeable symptoms.
Current infection (acute or chronic)
The virus is currently present in your blood. Whether this is a new (acute) infection your body may still clear, or a long-standing (chronic) infection present for more than six months, depends on how long HBsAg has been positive and the result of an IgM anti-HBc test. Your GP will arrange further testing and, if chronic, ongoing specialist or GP-led monitoring.
Isolated anti-HBc: several possible explanations
This less common pattern can mean a past infection where the protective anti-HBs antibody has faded over time (the most frequent explanation), a false-positive result, or in rare cases a low-level occult infection detectable only by a sensitive HBV DNA test. Your GP will usually repeat the panel and may add an HBV DNA test to clarify which of these applies.
Match your own three results to the pattern table
Upload your pathology PDF and SmarterBlood's AI will match your actual HBsAg, anti-HBs and anti-HBc results against the pattern table above, in plain English.
Upload Your ResultsSecond-Tier Tests: What They Add
Once HBsAg is confirmed positive, or an isolated anti-HBc result needs clarifying, these follow-up tests build a fuller picture of what is happening with the virus and the liver.
HBeAg and anti-HBe
Viral replication activityChecked once HBsAg is confirmed positive. HBeAg positive broadly suggests higher viral replication and higher infectiousness. HBeAg negative with anti-HBe positive generally suggests lower replication, though some HBeAg-negative viral variants still replicate significantly, which is why viral load testing is done alongside this.
Hepatitis B viral load (HBV DNA)
How much virus is presentA quantitative measure of virus particles in the blood, reported in international units per millilitre. Persistently high viral load is one of the main factors used, together with ALT and liver imaging, to decide whether antiviral treatment is needed. Also used to detect occult infection when HBsAg is negative but anti-HBc is isolated positive.
ALT (alanine aminotransferase)
Liver inflammationA liver enzyme that rises when liver cells are inflamed or damaged. Persistently elevated ALT alongside a high viral load points towards a phase of chronic hepatitis B that is actively causing liver damage and may need treatment. Normal ALT with a high viral load can still occur and is watched closely rather than ignored.
Liver ultrasound and FibroScan
Structural liver damage and stiffnessUltrasound looks for structural changes such as fatty change, nodularity, or signs of cirrhosis, and screens for liver masses. FibroScan (transient elastography) measures liver stiffness as a non-invasive proxy for the amount of scarring (fibrosis) present, avoiding the need for a liver biopsy in most people with chronic hepatitis B.
Alpha-fetoprotein (AFP)
Liver cancer surveillanceChronic hepatitis B carries an increased long-term risk of liver cancer (hepatocellular carcinoma), even in the absence of cirrhosis. AFP is checked periodically alongside six-monthly liver ultrasound as part of routine surveillance in people with chronic infection, particularly if there is a family history of liver cancer or existing cirrhosis.
Why Not Everyone With Chronic Hepatitis B Needs Treatment
Chronic hepatitis B is not one fixed state. It moves through recognised phases, defined by HBeAg status, viral load, and ALT, and treatment decisions follow the phase rather than the diagnosis label alone.
Immune-tolerant phase
Treatment needed: Usually not, but close monitoring continues
Immune-active (HBeAg-positive) phase
Treatment needed: Often yes, to reduce liver inflammation and damage
Immune-control (inactive carrier) phase
Treatment needed: Usually not, but lifelong monitoring continues
Immune-escape (HBeAg-negative) phase
Treatment needed: Often yes, this phase can still cause progressive liver damage
Who Is Recommended for Hepatitis B Testing in Australia
Australian guidelines recommend hepatitis B testing for the following groups, regardless of whether symptoms are present. Hepatitis B is often silent for years.
People born in, or with parents born in, a country with intermediate or high hepatitis B prevalence
Includes much of Asia, the Pacific, Sub-Saharan Africa, and parts of the Middle East and Eastern Europe. Vertical transmission at birth is a major route in these regions.
Aboriginal and Torres Strait Islander people
Higher prevalence historically recorded in some communities; testing and vaccination are a recognised public health priority.
Household and sexual contacts of someone with hepatitis B
Hepatitis B spreads through blood and body fluid contact, so close contacts need testing and, if not immune, vaccination.
People starting immunosuppressive treatment or chemotherapy
Reactivation risk during treatment makes pre-treatment testing mandatory in Australian clinical guidelines.
People who inject drugs, past or present
Blood-to-blood contact through shared injecting equipment is an efficient transmission route.
Men who have sex with men
Sexual transmission risk; vaccination is routinely offered if not already immune.
Healthcare and laboratory workers
Occupational exposure to blood and body fluids; most Australian health employers require documented immunity.
Pregnant women
Universal antenatal screening in Australia; a positive result triggers newborn immunoglobulin and vaccination to prevent transmission at birth.
People with unexplained abnormal liver function tests
Hepatitis B is one of the standard causes to exclude when ALT or AST is persistently raised without an obvious explanation.
Australian Context: Contacts, Notification and Immunosuppression
Hepatitis B is a notifiable condition
A new hepatitis B result meeting the case definition is reported by the laboratory to the relevant state or territory health department, as required for all nationally notifiable conditions in Australia. This is a routine public health administrative step used for tracking disease trends and supporting contact tracing, and it does not change how your GP explains or manages your own result.
Testing and vaccinating household and sexual contacts
Hepatitis B spreads through blood and body fluid contact. If you test positive for a current or past infection, it is important that household members and sexual partners are tested with the same three-part panel. Anyone who is found not to be immune and not currently infected should be offered the hepatitis B vaccine. Your GP or a sexual health clinic can coordinate this contact testing and vaccination.
Checking hepatitis B before immunosuppressive treatment or chemotherapy
This is one of the most clinically important reasons hepatitis B serology is checked. Chemotherapy, and other immunosuppressive treatments used for autoimmune conditions or organ transplantation, suppress the immune control that normally keeps hepatitis B quiet, even in someone with a resolved past infection. Without that control, the virus can reactivate, sometimes severely. Australian treatment guidelines require hepatitis B serology to be checked before these treatments start. A positive result usually leads to preventive antiviral medication being started alongside the treatment and continued for a period afterwards, under specialist supervision.
What Your GP Will Do Next
Confirm the pattern against your history
Your GP will check your three results together against the pattern table above, and ask about prior vaccination, prior blood tests, and any known family history of hepatitis B.
Repeat testing if the result is unclear
An isolated anti-HBc result, an equivocal result, or a first-time positive HBsAg is usually repeated on a fresh sample before anything is acted on, to rule out laboratory error.
Add second-tier tests if HBsAg is positive
HBeAg, anti-HBe, HBV DNA viral load, ALT, and a liver ultrasound are arranged to establish how active the infection is and whether the liver has been affected.
Arrange specialist referral if needed
Chronic hepatitis B with an active phase, evidence of liver damage, or a complex pattern is usually referred to a gastroenterologist, hepatologist, or infectious diseases physician for ongoing management.
Set a monitoring schedule
Even when treatment is not needed, chronic hepatitis B is monitored regularly, generally every six to twelve months, with liver function tests, viral load, and periodic liver cancer surveillance (ultrasound and AFP).
Arrange contact testing and vaccination
Household members and sexual partners are offered testing, and vaccination is offered to anyone found not to be immune and not currently infected.
When to Seek Urgent Care
Yellowing of the skin or eyes (jaundice), especially with a new positive result
Can indicate significant acute liver inflammation and needs same-day medical assessment.
Severe abdominal pain, persistent vomiting, or confusion alongside a known hepatitis B infection
These can be signs of acute liver failure, which is rare but serious and needs emergency assessment.
Known chronic hepatitis B and about to start chemotherapy or immunosuppressive treatment without hepatitis B having been checked first
Tell the treating team immediately; reactivation prevention needs to be arranged before, not after, treatment starts.
Pregnant and hepatitis B status is unknown
Contact your GP or antenatal provider promptly; timely testing allows newborn immunoglobulin and vaccination to prevent transmission at birth.
Sources and reference ranges
Adult reference ranges on this page follow the AACB and RCPA harmonised reference intervals unless stated otherwise; the range printed on your own report always takes precedence because laboratories differ.
Hepatitis B Blood Test Results: Frequently Asked Questions
What does HBsAg positive mean?
HBsAg (hepatitis B surface antigen) positive means the hepatitis B virus is currently present in your blood, whether the infection is brand new (acute) or has been present for more than six months (chronic). It is the single test used to first detect an active hepatitis B infection. A positive HBsAg result on its own does not distinguish acute from chronic infection; that distinction needs the duration of the result, an IgM anti-HBc test, and often HBeAg and viral load testing, all of which your GP will arrange. HBsAg positive does not mean you are immune, and it does not mean liver damage is definitely present. It means the virus needs further assessment.
What does anti-HBs positive mean?
Anti-HBs (hepatitis B surface antibody) positive means your immune system has produced protective antibodies against the hepatitis B surface antigen. This happens in two situations: successful vaccination, or full recovery from a past natural infection. If anti-HBs is positive and anti-HBc is negative, the antibodies almost always came from vaccination, and you are immune. If both anti-HBs and anti-HBc are positive, the antibodies came from a past infection that has fully resolved, and you are also immune. Either way, a positive anti-HBs result is reassuring: it means you are protected against future hepatitis B infection.
What does anti-HBc positive mean if HBsAg is negative?
Anti-HBc (hepatitis B core antibody) positive with a negative HBsAg usually means you were exposed to hepatitis B in the past and your body cleared the infection. If anti-HBs is also positive, this pattern confirms past infection with full recovery and lasting immunity, which is a very common and reassuring result. If anti-HBc is positive but anti-HBs is negative (an isolated anti-HBc result), the picture is less clear cut and there are several possible explanations, including a resolved infection where the protective antibody has faded over time, a false positive test, or in rare cases a low-level occult infection. Your GP will usually repeat the panel and may add a hepatitis B viral load (HBV DNA) test to clarify which explanation applies to you.
How do I know if I have chronic hepatitis B or just a resolved past infection?
The key test is HBsAg. If HBsAg is negative, whether or not anti-HBc is positive, you do not have a current infection; you have either been vaccinated or cleared a past infection. If HBsAg is positive, an infection is currently present. It is called chronic hepatitis B when HBsAg remains positive for more than six months. Before six months have passed, a positive HBsAg is classified as an acute infection, which in most healthy adults clears on its own within that window. Your GP tracks this with repeat HBsAg testing over time, alongside IgM anti-HBc (positive in early acute infection, negative in chronic infection) to help pin down the timeline.
Do I need treatment if I have chronic hepatitis B?
Not automatically. Chronic hepatitis B moves through recognised phases, and antiviral treatment is reserved for the phases where the virus is replicating actively and causing liver inflammation or damage, generally shown by a raised viral load together with an elevated ALT and evidence of liver damage on imaging or a FibroScan. Many people with chronic hepatitis B are in an immune-control phase where the virus is present but quiet, ALT is normal, and treatment is not needed. Everyone with chronic hepatitis B needs regular monitoring, typically every six to twelve months, even during the phases that do not need medication, because the disease can move between phases over time.
Should my family be tested for hepatitis B?
Yes. Hepatitis B spreads through blood and body fluids, including from mother to baby at birth, sexual contact, and sharing items that carry trace blood such as razors or toothbrushes. If you test positive for a current or past hepatitis B infection, household members and sexual partners should be tested with the same three-part panel (HBsAg, anti-HBs, anti-HBc). Anyone who is not immune and not currently infected should be offered the hepatitis B vaccine. This is a standard and important part of managing a hepatitis B diagnosis in Australia, and your GP or a sexual health clinic can arrange contact testing.
Why do I need a hepatitis B test before chemotherapy?
Chemotherapy and other immunosuppressive treatments (including some medications for autoimmune conditions and organ transplant drugs) suppress the immune system, which normally keeps hepatitis B in check even in someone who has recovered from a past infection or has quiet chronic infection. Without that immune control, the virus can reactivate, sometimes causing severe and even life-threatening liver inflammation. Australian treatment guidelines require hepatitis B serology to be checked before starting these treatments. If you test positive for current or past infection, your specialist will usually arrange preventive antiviral medication to cover the treatment period and taper it off afterwards under supervision.
Is hepatitis B notifiable in Australia?
Yes. Hepatitis B is a nationally notifiable condition in Australia. When a laboratory identifies a new hepatitis B result meeting the case definition, it is reported to the relevant state or territory health department, which tracks cases for public health purposes such as contact tracing support and monitoring disease trends. This is a routine administrative process, handled between the laboratory and health authorities, and does not change how your own results are explained to you or how your care is managed by your GP.
What is the difference between HBeAg and HBsAg?
HBsAg (surface antigen) simply tells you whether hepatitis B virus is present at all. HBeAg (e-antigen) is a separate marker checked once HBsAg is positive, and it broadly reflects how actively the virus is replicating and how infectious the blood is. HBeAg positive generally suggests higher viral activity, while HBeAg negative with a positive anti-HBe antibody generally suggests lower activity, though some HBeAg-negative variants of the virus can still replicate significantly. Your GP or specialist combines HBeAg and anti-HBe status with hepatitis B viral load (HBV DNA) and ALT to work out which phase of chronic hepatitis B you are in and whether treatment is needed.
Related Reading
Got Your Hepatitis B Results?
Upload your pathology PDF and SmarterBlood's AI will explain your HBsAg, anti-HBs and anti-HBc results, plus your liver function tests, in plain English with Australian reference ranges.
This page provides general educational information about hepatitis B serology testing. It is not a substitute for professional medical advice, diagnosis, or treatment. Only your GP, after reviewing your full results and medical history, can explain what your hepatitis B status means for you and what monitoring or treatment, if any, you need. SmarterBlood does not provide medical care.